Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion type Assertion NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_head.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion description "[Thirty-five of 49 (71.4 percent) serrated adenomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and 8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxygenase-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_provenance.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion evidence source_evidence_literature NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_provenance.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion SIO_000772 11584208 NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_provenance.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion wasDerivedFrom befree-2016 NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_provenance.
- NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_assertion wasGeneratedBy ECO_0000203 NP331755.RATioYk1kVYCNuwPJ2jFbrGelBy6Q2__-RMTpI1g62QDU130_provenance.